OPKO Health Inc (OPK)
1.52
+0.03
(+2.01%)
USD |
NASDAQ |
Sep 27, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
OPKO Health Research and Development Expense (TTM): 84.85M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 84.85M |
| March 31, 2024 | 78.92M |
| December 31, 2023 | 89.59M |
| September 30, 2023 | 89.73M |
| June 30, 2023 | 89.08M |
| March 31, 2023 | 88.18M |
| December 31, 2022 | 73.89M |
| September 30, 2022 | 75.36M |
| June 30, 2022 | 74.88M |
| March 31, 2022 | 75.85M |
| December 31, 2021 | 76.85M |
| September 30, 2021 | 73.30M |
| June 30, 2021 | 73.48M |
| March 31, 2021 | 72.87M |
| December 31, 2020 | 75.32M |
| September 30, 2020 | 80.90M |
| June 30, 2020 | 92.42M |
| March 31, 2020 | 103.10M |
| December 31, 2019 | 117.87M |
| September 30, 2019 | 128.16M |
| June 30, 2019 | 128.30M |
| March 31, 2019 | 129.23M |
| December 31, 2018 | 125.59M |
| September 30, 2018 | 126.50M |
| June 30, 2018 | 128.85M |
| Date | Value |
|---|---|
| March 31, 2018 | 132.76M |
| December 31, 2017 | 126.44M |
| September 30, 2017 | 122.47M |
| June 30, 2017 | 114.39M |
| March 31, 2017 | 112.61M |
| December 31, 2016 | 113.87M |
| September 30, 2016 | 109.07M |
| June 30, 2016 | 103.58M |
| March 31, 2016 | 101.81M |
| December 31, 2015 | 99.49M |
| September 30, 2015 | 99.84M |
| June 30, 2015 | 101.42M |
| March 31, 2015 | 88.08M |
| December 31, 2014 | 83.57M |
| September 30, 2014 | 81.10M |
| June 30, 2014 | 71.66M |
| March 31, 2014 | 64.99M |
| December 31, 2013 | 53.90M |
| September 30, 2013 | 37.13M |
| June 30, 2013 | 29.67M |
| March 31, 2013 | 24.60M |
| December 31, 2012 | 19.52M |
| September 30, 2012 | 17.20M |
| June 30, 2012 | 16.88M |
| March 31, 2012 | 15.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
72.87M
Minimum
Mar 2021
128.16M
Maximum
Sep 2019
85.73M
Average
79.91M
Median
Research and Development Expense (TTM) Benchmarks
| Innerscope Hearing Technologies Inc | -- |
| Abbott Laboratories | 2.754B |
| Boston Scientific Corp | 1.468B |
| ICU Medical Inc | 88.51M |
| Outset Medical Inc | 50.98M |